Results 291 to 300 of about 187,246 (326)
Some of the next articles are maybe not open access.

Cutaneous T cell lymphoma

Nature Reviews Disease Primers, 2021
Primary cutaneous T cell lymphomas (CTCLs) are a heterogeneous group of lymphomas that present in the skin with no evidence of extracutaneous disease at the time of diagnosis. CTCL subtypes demonstrate a variety of clinical, histological, and molecular features, and can follow an indolent or a very aggressive course.
R. Dummer   +8 more
semanticscholar   +5 more sources

Cutaneous T-Cell Lymphoma

Seminars in Oncology Nursing, 2006
To review recent information on the epidemiology, etiology, clinical presentation, staging, treatment approaches, and nursing management of CTCL.Research and review articles and textbooks.Identifying the etiology and finding a cure for cutaneous T-cell lymphoma is promising as our knowledge and understanding of the T-cell biology evolves, creating more
Perez, A, Whittaker, S
openaire   +5 more sources

Cutaneous T-cell Lymphoma

Hematology/Oncology Clinics of North America, 2008
Cutaneous T-cell lymphoma comprises a heterogeneous group of lymphoproliferative disorders characterized by clonal expansions of mature, post-thymic T cells that infiltrate the skin. This article discusses the staging, prognosis, and treatment of mycosis fungoides and Sézary syndrome.
Frederick Lansigan   +2 more
openaire   +5 more sources

Cutaneous T-cell lymphoma

Journal of the American Academy of Dermatology, 2004
Cutaneous T-cell lymphomas arise in the skin and are classified by their clinical presentation and cell surface markers. Mycosis fungoides and the Sezary syndrome are the most frequently encountered, followed by the CD30+ lymphoproliferative disorders.
Madeleine Duvic, Richard L. Edelson
openaire   +4 more sources

Cutaneous T-cell lymphomas

Current Opinion in Oncology, 1993
Cutaneous T-cell lymphoma, which usually presents as mycosis fungoides or Sézary syndrome, remains a mostly incurable, yet highly treatable group of diseases. The myriad of active therapies continues to grow, and new insights into the mechanism of systemic and topical therapies are being elucidated.
Edward H. Kaplan, William T. Leslie
openaire   +3 more sources

Cutaneous T cell Lymphoma

The Journal of Dermatology, 1980
AbstractCutaneous T cell lymphoma (CTCL) is a generic classification of clonally‐derived malignancies of phenotypic helper/inducer T cells with a propensity to infiltrate the skin, migrate into the epidermis, localize in T cell zones of lymphoid structures and spare the bone marrow.
openaire   +4 more sources

Cutaneous T-Cell Lymphoma

2014
Cutaneous T-cell lymphoma (CTCL) represents a spectrum of the non-Hodgkin's lymphomas, including mycosis fungoides (MFs) and Sezary syndrome. Although an uncommon malignancy, the number of new cases per year in the United States is increasing at a constant rate.
Kuzel Tm, Gilyon K
openaire   +5 more sources

Cutaneous lesions of angioimmunoblastic T‐cell lymphoma: Clinical, pathological, and immunophenotypic features

Journal of cutaneous pathology, 2019
Angioimmunoblastic T‐cell lymphoma (AITL) is a systemic peripheral T‐cell lymphoma with a follicular helper T‐cell (TFH) immunophenotype that frequently involves the skin.
Naoki Oishi   +6 more
semanticscholar   +1 more source

Cutaneous T-cell lymphomas

Seminars in Oncology Nursing, 1998
To describe the current state of the knowledge regarding the pathology, clinical presentation, treatment strategies, and nursing management of patients with cutaneous T-cell lymphoma, specifically, mycosis fungoides and the Sezary syndrome.Book chapters, review articles, published research studies, proceedings from professional meetings.Although ...
openaire   +3 more sources

Home - About - Disclaimer - Privacy